Valuation: Frontage Holdings Corporation

Capitalization 272M 2.13B 230M 212M 201M 372M 25.16B 378M 2.48B 973M 12.2B 1.02B 999M 42.99B P/E ratio 2025 *
-
P/E ratio 2026 * 32.9x
Enterprise value 291M 2.28B 247M 227M 215M 398M 26.94B 405M 2.66B 1.04B 13.06B 1.09B 1.07B 46.02B EV / Sales 2025
1.16x
EV / Sales 2026 * 0.99x
Free-Float
27.58%
Yield 2025 *
-
Yield 2026 * -
1 day+0.96%
1 week+3.96%
Current month-4.55%
1 month-8.70%
6 months-4.55%
Current year+5.00%
1 week 1
Extreme 1
1.05
1 month 1
Extreme 1
1.15
Current year 0.9
Extreme 0.9
1.16
1 year 0.9
Extreme 0.9
1.87
3 years 0.47
Extreme 0.47
2.58
5 years 0.47
Extreme 0.47
9.18
10 years 0.47
Extreme 0.47
9.18
Manager TitleAgeSince
Chief Executive Officer 62 2025-01-05
Chief Executive Officer 57 2025-01-05
Corporate Officer/Principal 63 2017-05-31
Director TitleAgeSince
Director/Board Member 68 2018-03-31
Director/Board Member 62 -
Director/Board Member 58 2018-03-31
Change 5d. change 1-year change 3-years change Capi.($)
+0.96%+3.96%-10.26%-59.14% 272M
+2.22%+5.51%+0.78%-7.33% 48.69B
+0.99%+4.59%+40.22%+21.40% 35.92B
-0.43%+54.13%+304.33%+512.40% 31.26B
-0.72%+3.91%+37.10%+32.51% 29.77B
+2.62%+5.45%+22.62%-12.96% 29.62B
+0.63%+2.17%+48.12%+200.79% 15.1B
+0.96%+5.48%+75.71%+171.60% 14.87B
+0.87%+8.85%+40.89%+13.75% 14.5B
-6.22%-0.52%+3,641.35%+3,861.59% 14.18B
Average +0.19%+9.22%+420.09%+473.46% 23.42B
Weighted average by Cap. +0.58%+11.11%+285.40%+331.04%

Financials

2025 2026 *
Net sales 256M 2.01B 217M 200M 189M 350M 23.7B 356M 2.34B 917M 11.49B 961M 941M 40.49B 282M 2.21B 239M 220M 208M 385M 26.07B 392M 2.57B 1.01B 12.64B 1.06B 1.03B 44.54B
Net income 7.31M 57.24M 6.19M 5.7M 5.39M 9.99M 676M 10.17M 66.74M 26.17M 328M 27.42M 26.85M 1.16B 7.95M 62.23M 6.73M 6.19M 5.86M 10.87M 735M 11.06M 72.55M 28.45M 357M 29.81M 29.19M 1.26B
Net Debt 19.19M 150M 16.25M 14.96M 14.15M 26.23M 1.78B 26.69M 175M 68.68M 861M 71.98M 70.48M 3.03B 6.89M 53.96M 5.84M 5.37M 5.08M 9.42M 638M 9.59M 62.91M 24.67M 309M 25.85M 25.32M 1.09B
Logo Frontage Holdings Corporation
Frontage Holdings Corporation is a holding company. The Company provides laboratory and related services to pharmaceutical and agrochemical companies as well as bioequivalence clinical and chemical services. The Company has two main divisions: Global Drug Discovery & Development Services and Global Laboratory Services. The Global Drug Discovery & Development Services division includes Drug Development Unit, Drug Discovery Unit and Pharmaceutical Product Development Unit. The Global Laboratory Services division offers laboratory testing support for clients involved in drug development. Its Global Laboratory Services encompass regulated and non-regulated bioanalysis (both small and large molecules), biomarkers, genomics, manufacturing and controls analytical testing, and central laboratory services. The Company's segments include North America and Europe, and PRC. The North America and Europe segment includes United States, Canada and Europe. The PRC segment includes China.
Employees
1,523
Date Price Change Volume
26-04-17 1.050 $ +0.96% 18,000
26-04-16 1.040 $ +0.97% 16,000
26-04-15 1.030 $ +0.98% 102,000
26-04-14 1.020 $ +0.99% 84,000
26-04-13 1.010 $ 0.00% 10,000
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
0.1341USD
Average target price
0.1285USD
Spread / Average Target
-4.18%

Quarterly revenue - Rate of surprise